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Synthesis and characterisation of bioactive
and antibacterial glass–ceramic Part 1 –
Microstructure, properties and biological
behaviour
E. Verne´*1, S. Ferraris1, M. Miola1, G. Fucale2, G. Maina3, G. Martinasso4,
R. A. Canuto4, S. Di Nunzio1,5 and C. Vitale-Brovarone1
A glass–ceramic composition has been studied to realise a highly bioactive material, suitable for
stimulate the bone regeneration, which has been subjected to a patented ion exchange process
with silver ions, to impart antibacterial properties. The obtained material has been characterised
by SEM, EDS and XRD analyses, before and after the introduction of Agz ions, and has been
subjected to mechanical tests. Agz release was verified by GF-AAS analysis. The influence of
silver on material wettability and bioactivity was evaluated through contact angle measurements
and in vitro test on SBF solution. Finally, biocompatibility with osteoblast like cells and antibacterial
test on Staphylococcus Aureus, have been realised to demonstrate the effective antimicrobial
behaviour and the safety of silver doped glass–ceramic. On the basis of this study, it was evinced
that ion exchange technique, optimised on glasses in previous research works, allows the
controlled introduction of Agz ions and can be transferred on medical devices totally or partially
realised with bioactive glass–ceramic.
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Introduction
A typical problem connected with the implant of a
medical device is the development of infections, due to
bacteria adhesion and colonisation onto biomaterial
surfaces. This situation often causes the failure of the
implant and increases the hospital costs. Systemic
antibiotic prophylaxis and special antiseptic operative
procedures do not eliminate the infection rates, which
range from 1 to 3% in total joint replacements.1,2
Bacteria compete with the cells of the body’s immune
system to colonise the surface of the implant. Moreover,
the body’s immune system is locally weakened by the
presence of a foreign body and an injured bone. The
production of extracellular biofilms on the surface of
the implants often results in a very low efficacy of both
body’s immune system response and systemic prophy-
laxis. For these reasons, if bacteria colonise the surface
of the implant and its immediate surroundings, the
possibility of developing an infection is very high. Thus,
the use of implantable devices with an antibacterial
surface, which starts releasing the active substance from
the very first moment of implantation, represents a valid
possibility to avoid bacterial colonisation and infections.
Silver, in the form of silver sulfadiazine, is one of the
antibacterial agents utilised from years in different fields
of medicine for the treatment of infections, particularly
the ones associated with burns, because it shows a broad
antibacterial behaviour.3,4 Even if a not negligible clinical
cytotoxicity has been reported,5–8 silver is widely used in
wound healing9,10 and in different biomaterials.11–14 This
antimicrobial agent, in contrast to antibiotics, interferes
with bacterial cells in different ways: it interacts with
DNA and with proteins essential for bacterial respiration
and transport of substances across cell membrane,
inhibits the cell division and induces the rupture of cell
membrane; for these reasons, the bacterial resistance is
very limited. The activity of silver is defined as
oligodynamic because at low concentration, the effect is
interested in particular small prokaryotic cells (typically
bacteria) while at higher concentration also eukaryotic
cells are damaged. There is a range of silver concentra-
tion, defined as ‘therapeutic window’,14 which allows an
antibacterial but not cytotoxic behaviour.
Lots of studies consider the use of silver to prevent
prosthetic infection. The proposed solutions are
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different: some authors realised coatings of pure metallic
silver on stainless steel pins for orthopedic fixation15 and
others introduced silver in the material composition,16,17
but the main difficulty remains in tailoring the amount
of introduced silver in order to achieve an antibacterial
behavior while maintaining biocompatibility.
Glasses and glass–ceramic with proper compositions
in a well known compositional range,18,19 show bio-
compatibility and bioactive properties since they are
able, by a complex mechanism involving ion leaching
with the surrounding biological fluids, to induce the
precipitation of hydroxyapatite on their surfaces. This
layer of hydroxyapatite is considered as itself by the
surrounding living tissues, thus its presence is widely
recognised to be a sufficient requirement for the implant
to bond with the living bone.20,21 These materials are
widely studied and already used in different forms such
as granules, bulk or coating materials in several
applications where a chemical bond with the surround-
ing bone is highly required.22–27
Silver containing bioactive glasses have been pro-
duced in different ways (melting and sol–gel):28–30 in
order to produce silver containing bioactive glasses, the
conventional meltquenching method is not effective to
assure a reproducible silver ion distribution;31 this is the
reason why up to date, only the sol–gel method has been
proposed in literature for this purpose. However, the
ionic diffusion in glasses can be successfully used aiming
to modify their surface composition.32 The amount of
silver introduced in material composition in bulk form is
higher than that of the one added through a surface
modification. On the other hand, the only useful silver is
the one that could be released from surface in direct
contact with injured tissues.
The aim of this work is to introduce a controlled and
limited amount of silver on the surface of a bioactive
glass–ceramic, to confer an antibacterial but not
cytotoxic effect. For this purpose, the ion exchange
technique, previously used to introduce silver in glasses
of simple composition and low bioactivity index,33,34
was applied for the first time to a bioactive glass–
ceramic of complex composition, aiming to develop, in
an effective, quick and reproducible way, a new bone
substitute able to promote both osteointegration and
low infection risk.
Materials and methods
Synthesis of glass–ceramic
The material studied in this work is a glass–ceramic with
the following molar composition: 50SiO2–18CaO–
9CaF2–7Na2O–7K2O–6P2O5–3MgO. This composition
belongs to a system in which the nucleation of
fluorapatite is favourite35,36 and was chosen to obtain
a bioactive glass–ceramic with ion exchange potential-
ities. The glass–ceramic, named Fa-GC from now on,
was prepared by conventional melt and quenching
route, followed by sintering at opportune conditions,
in order to obtain a controlled and reproducible
devitrification of the parent glass. The starting compo-
nents have been melted in a platinum crucible at 1550uC
for 1 h. Since the melt is prone to spontaneous and
inhomogeneous devitrification during cooling, it was
not poured in a mould, but quenched in cold water, in
order to minimise this phenomenon. The obtained frit
was then milled and sieved down to a grain size of
30–75 mm.
Sintering process optimisation
The characteristic temperatures of the parent glass were
identified by means of differential thermal analysis
(DTA Netzsch 404S) and differential scanning calori-
metry (Perkin-Elmer DSC 7) performed on the sieved
powders. The linear shrinkage and the optimal sintering
temperatures of the glass–ceramic were estimated by
means of hot stage microscopy, in the temperature range
between 25 and 1000uC on cubic green compacts of
36363 mm in size.
The powders have been uniaxially pressed obtaining
green compacts of 565640 mm in size. The green
compact have been subsequently sintered using different
temperature and time schedules, chosen on the basis of
the previous thermal analyses. After a preliminary
characterisation of the sintered samples obtained in
different conditions, the optimal sintering schedule has
been individuated and used to produce samples for
surface modification.
Characterisation of sintered samples
Structural analyses were performed by means of X-ray
diffraction (X’Pert Philips diffractometer: Bragg–
Brentano configuration and Cu Ka incident radiation),
to identify the crystalline phases formed during sinter-
ing. The crystalline phases were observed also by
scanning electron microscopy (SEM Philips 525M) on
chemically etched sintered samples and analysed by EDS
(Philips, EDAX 9100).
The sintered glass–ceramic has been subjected to a
complete mechanical characterisation: the Young’s
modulus was evaluated by means of acoustic method
(Grindosonic) on sintered bars and the Vickers indenta-
tions were performed to estimate the hardness (HV) and
the fracture toughness (KIC) of the glass–ceramic, using
a load of 10 kg and the following equation
HV~2F
sin 1360=2ð Þ
l2
~1854
F
l2
 
KIC~0:016(E=HV)
1=2
(P=c3=2)
where F and P are the load applied, l is the diagonals
mean of the mark, E is the Young’s modulus and c is the
crack length. Before the hardness test, the samples were
polished with 1 mm diamond paste.
To verify the material strength, flexural tests with
three and four points bend loading geometry (dimen-
sions: 5261064 mm) were performed. The flexural
strength was calculated from the standard equation
s~
3
2
Fl
b2a
where F is the applied load, l is the distance between the
supports, and a and b are the parameters of the section.
The maxima inflexion was valuated using the following
equation
gmax~
Fl3
24EJ
where E is the glass–ceramic elastic modulus and J is the
inertia of the section.
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Surface modification
To introduce silver inside the glass–ceramic, an ion
exchange process has been selected. This technique
focuses particularly on the amorphous phase of the
material and is based on the exchange of modifier
cations (especially Naz ions) with silver ions of the
solution.33,34 This process allows the introduction of
silver ions only in the outer layers of the samples,
maintaining unaltered bulk characteristics, such as
mechanical properties and bioactivity.
In this work, the ion exchange process was performed
in aqueous solution of silver nitrate, following a
protocol described elsewhere.37 Samples modified by
this technique will be named Ag-GC from now on.
The samples were analysed by means of X-ray
diffraction, SEM and EDS to evaluate the modification
induced by the ion exchange process.
In vitro bioactivity
In order to evaluate bioactive behaviour of both
unmodified glass–ceramic and Ag-GC, samples were
soaked in simulated body fluid (SBF) for up to 1 month
at 37uC. A refresh of the solution was made every 2 days
to mimic physiological turnover of body fluids; at the
same time, the pH of the solution was monitored. The
SBF used in this work is the one proposed by Kokubo
and it mimics the inorganic salt composition of human
physiological fluids.18–20,38
Wettability
Surface wettability was determined by measurement of
static contact angle with water, before and after ion
exchange process, to verify the eventual modifications
due to the presence of silver.
Water was used because the biological fluids are
composed in the greater part by water and the test was
performed because the hydrophobic/hydrophilic beha-
viour is significant in the cellular tests, as research works
in literature confirm39,40 that bacteria preferentially
adhere on hydrophilic surfaces rather than on hydro-
phobic ones.
Leaching tests
The amount of released silver ions was investigated by
soaking Ag-GC samples in SBF for up to 1 month at
37uC without refreshing. Graphite furnace-atomic
adsorption spectrophotometry (GF-AAS, Perkin-Elmer
4100 ZL) analyses were performed in 1 mL SBF spiked
from the soaking solution after 3 h and 1, 3, 7, 14 and
28 days dipping. The leaching tests were performed in
triplicate and for comparative purposes, also one
unmodified glass–ceramic with the same dimensions,
was tested.
Biocompatibility tests
Since Ag-GC is intended for bone tissue integration,
biocompatibility and cytotoxicity tests were carried out
on human osteoblast-like cells (MG-63). Samples of as
sintered Fa-GC and of Ag-GC were soaked in minimum
essential medium (M5650 Sigma) added with 1 mM
sodium pyruvate, 1% antibiotics and antimycotics
solutions, 2 mM glutamine and 10% serum. After
24 h, 10 000 cells/cm2 were seeded on samples and
maintained for 2, 4 and 8 days at 37uC in the
atmosphere of 5%CO2 and 95% air. Tests were
performed, at each time, part on cells (optical
microscope observation, count, SEM observation) and
part on the supernatant (pH and lactate dehydrogenase
measurements). All tests were performed in triplicate.
Optical microscope observation describes the presence
and morphology of cells around the sample and is a
qualitative index of material’s biocompatibility. Vital
count, performed using trypan blue colorant, is a
quantitative index of cells’ vitality in the presence of
Fa-GC and Ag-GC.
In order to evaluate the presence and the morphology
of cells on samples surface, specimens were fixed and
observed by SEM. pH is a measure of cellular metabolic
activity, and in particular medium’s acidification shows
good cell’s metabolism. The presence of lactate dehy-
drogenase (LDH) is an index of cellular death for
necrosis. Lactate dehydrogenase (LDH) is measured by
spectrophotometry.
Antibacterial tests
Two kinds of microbiological tests have been performed
in accordance to NCCLS standards for antimicrobial
susceptibility: inhibition zone evaluation41 and broth
dilution tests.42 All products for this analysis have been
purchased from BD-Becton Dickinson.
In both cases, a bacterial broth has been prepared
dissolving a S. Aureus disc (ATCC 29213) in 5 mL brain
heart infusion. After overnight incubation at 37uC,
10 mL suspension has been spread on a blood agar plate
and incubated for 24 h. A 0?5 McFarland suspension
(containing approximately 1–26108 CFU mL21) has
been prepared inoculating some colonies grown on the
plate in physiological solution (turbidity has been
evaluated by optical instrument, Phoenix Spec BD
McFarland)
In order to carry out inhibition zone evaluation, an
aliquot of the described suspension has been spread on
Mueller–Hinton agar plates on which samples have then
been posed with the treated surface in contact with plate.
After 24 h incubation, inhibition zones have been
observed as a halo around samples where bacteria did
not grown up.
In order to perform dilution tests, an aliquot of
bacterial suspension has been introduced in Mueller–
Hinton broth tubes in order to obtain suspensions
containing y56105 CFU mL21.
A tube containing only bacteria has been prepared as
growth control, and in the other tubes, samples and
silver containing samples have been introduced.
After 24 h incubation at 35uC, tubes’ turbidity has
been optically evaluated (Phoenix Spec BD McFarland).
As for samples broth, washing and vortexing solu-
tions have been analysed in order to quantify colony
forming units (CFU). The washing solution has been
prepared by rapid rinsing of sample in physiological
solution, while the vortexing one is prepared by 1 min
50 Hz vortex of sample in physiological solution.
Each solution has been serially diluted and spread on
blood agar plates. After overnight incubation at 35uC,
CFU have been counted on plates. Each test has been
carried out in triplicate.
Results and discussion
Thermal analyses
Thermal analyses (DTA and DSC) allow the identifica-
tion of the material characteristic temperatures: glass
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transition temperature Tg, crystallisation temperature Tx
and liquidus temperature Tl. The diagrams (Fig. 1) have
shown two exothermic crystallisation peaks at 730 and
780uC, related to two crystalline phases; the onset
temperature of the first peak is 620uC.
The liquid temperatures of the two crystalline phases
have been identified at 900 and 1310uC and the glass
transition temperature Tg is 518uC.
To investigate the shrinkage of the green compacts
and the influence of the two crystallisation phenomena
on this step, a dilatometric analysis was performed, by
means of hot stage microscopy from room temperature
to 1000uC. Figure 2 shows the graphs relative to hot
stage microscopy in the temperature range 200–1000uC:
at 500uC, the sample expands slightly; between 550 and
625uC, it become to shrink; this behaviour is due to
viscous flowing of the amorphous phase and initial
sintering. From 675 to 850uC, a range in which two
crystallisation processes are occurring, the sample starts
again to expand and finally at higher temperature, the
softening begins.
The optimal sintering temperatures were chosen on
the basis of the thermal analyses. The green bars were
sintered at 650 and 800uC, i.e. the temperature of the
maximum shrinkage, and for comparison purposes, the
nearer temperature to the liquid phase formation
respectively. The samples were initially sintered for
3 h, then, after SEM observation and density estima-
tion, the sintering time was reduced to 1 h.
As expected, XRD phase analysis shows that the as
prepared glass contains a little amount of apatite
(probably fluorapatite, due to the composition of the
glass) in the amorphous matrix (Fig. 3a). After the
thermal treatment, both at 650 and 800uC, fluorapatite
signals grow in a significant way, and another crystalline
phase, identified as canasite, is detected (Fig. 3b and c).
These results agree with thermal analyses and demon-
strate that crystalline phases are present only in few
amounts immediately after the pouring and increase
during the thermal treatments. No other crystalline
phase appears in this process. Scanning electron micro-
scopy (SEM) and EDS observations demonstrate the
presence of the two phases (Fig. 4).
Mechanical tests
Vickers indentations were performed on a set of three
Fa-GC specimens sintered at the two chosen tempera-
tures, to study the cracks propagation and hardness.
Vickers hardness measured on samples sintered at 650uC
is higher that that measured on samples sintered at
800uC (HV65055?62¡0?66 GN m
22; HV80054?67¡
1?55 GN m22). This feature is probably due to the
expansion occurred above 650uC, which causes a lower
density of samples sintered at 800uC that compromises
the mechanical properties. For this reason, a complete
mechanical characterisation was performed only Fa-GC
bars sintered at 650uC.
The calculated fractures toughness was about
0?92¡0?08 MPa m21, a value comparable with other
data found in literature for glass–ceramics used in
odontology.43 The elastic modulus, valuated by means
of acoustic method, is 54 GPa.
The flexural strength was 68¡6 MPa for three points
flexure and 72¡6 MPa for four points flexure; these
results are interesting, because the human bone flexural
strength is included between 49 and 180 MPa.44,45
On the basis of these results, surface modification of
Fa-GC and its further characterisations, were performed
only on samples sintered at 650uC for 1 h.
Surface modification
The aim of this research is the realisation of an
antibacterial surface able to reduce the bacterial adhe-
sion and proliferation, without compromising substrate
properties, such as biocompatibility and mechanical
resistance. In order that a medical device has anti-
microbial properties, it is necessary to produce an
antibacterial surface, which is the device portion that
comes in contact with human body, fluids, tissues, cells
and also bacteria. For this reason, it is not essential to
impart antibacterial properties to the substrate; more-
over, silver ions coming from the internal bulk could be
trapped and accumulated between the implant and the
new formed tissue, causing toxic effect or the argyria.
Ion exchange technique allows the introduction of
silver ions only in the upper atomic layers of the
material, which is demonstrated by EDS analysis at
different voltages. In this way, a qualitative diffusion
profile of silver in sample’s depth was realised, as shown
in Fig. 5. As demonstrate in previously researches,33,34
the patented process permits to control and tune the
amount of silver introduced varying process parameters,
in function of material composition. In particular, the
1 Thermal analysis diagrams of a DTA and b DSC (upper
curve is derivative) on Fa-GC
2 Linear shrinkage of Fa-GC green compact
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ion exchange parameters allow modulating the thickness
depth of silver doped layer and to realise a thin layer
containing Agz ions, thus obtaining an immediate
release and maintaining the bulk characteristics
unchanged.
X-ray diffraction (XRD) analyses, before and after
ion exchange process, show that no new crystalline
phase grows during the treatment (Fig. 6). This means
that silver ions entered into the network of the residual
amorphous phase of Fa-GC without uncontrolled
reactions, such as, for example, the formation of silver
phosphates. Moreover, the amount of introduced silver
and the process conditions did not induce the reduction
of silver ions to metallic silver clusters, at least how far
was detectable by conventional XRD.
Sample’s morphology is maintained after treatment,
as observed by SEM. Analysis by EDS shows the
appearance of small silver’s peak; the amount of
quantified silver by EDS is included in the instrument
error limits (Fig. 7).
Weights of samples have been measured before and
after ion exchange process, and no variations are
observed (Table 1), inidicating that the treatment does
not induce any dissolution phenomena and that the
limited amount of introduced silver is not detectable
through this measurement, as on the contrary, realised
3 XRD patterns of Fa-GC at a 25uC, and after thermal treatment at b 650 and c 800uC
4 SEM and EDS analyses of Fa-GC show presence of two crystalline phases
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in the previous work.33 The results are in accordance to
SEM observations.
In vitro tests
In order to evaluate the bioactivity of the glass–ceramic
before and after ion exchange process, samples soaked
in SBF for up to 1 month, were analysed by XRD and
observed by SEM. After 14 day dipping, XRD patterns
indicate the formation of a hydroxyapatite layer (HAp)
on both surfaces of Fa-GC and Ag-GC samples.
Scanning electron microscopy (SEM) images show the
5 Ag profile and SEM image with modified layer underlined in box
6 XRD spectra of a GC and b Ag-GC
7 EDS analyses a before and b after ion exchange process, including SEM image
Table 1 Weight of sample before and after ion exchange
Initial weight, g Final weight, g
Mean 0.3106 0.3102
Standard deviation 0.0072 0.0073
Verne´ et al. Synthesis and characterisation of bioactive and antibacterial glass–ceramic: Part 1
Advances in Applied Ceramics 2008 VOL 107 NO 5 239
presence of uniform layer of a substance with the typical
globular morphology of HAp, and EDS analysis
confirms the enrichment in Ca and P for both samples
(Figs. 8 and 9). This result indicates that Fa-GC is a
bioactive glass–ceramic38 and that silver introduction by
ion exchange technique does not affect material’s
bioactive behaviour.
The trend of pH during the dipping period shows little
variations, in accordance to physiological values. The
most critical tissue as for pH variation tolerability is
blood, its pH must be quite constant around the value of
7?4 (7?35–7?45) and the maximum variations tolerated
are in the range 7?0–7?8. Typical pH for human tissular
cells is around 6?9. Figure 10 shows pH trend for Fa-GC
and Ag-GC, and pH tolerability range for blood, any
difference was observed in pH trend between Fa-GC and
Ag-GC. Then, even the silver is introduced on glass–
ceramic surface, it does not interfere with bioactivity
process mechanisms that really involve materials surface;
it is very interesting to realise a device both antibacterial
and bioactive, which promotes the osteointegration
through the formation of apatite layer on its surface.
Leaching test
In order to quantify the amount of silver released in
solution from the doped glass–ceramic, eluates of Ag-
GC, soaked in SBF, were analysed at different soaking
times by GF-AAS technique. Figure 11 shows the
amount of silver in solution, expressed in mg mm22,
and leaching speed, expressed in mg lhmm22.
a SEM image; b EDS spectrum
8 HAp on Fa-GC after 14 days in SBF
a SEM image; b EDS spectrum
9 HAp on Ag-Fa-GC after 14 days in SBF
10 pH trend and physiological tolerability range (in box)
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The leaching trend demonstrates that silver, intro-
duced in the glass–ceramic by ion exchange, is gradually
released in SBF and particularly in the first period,
which is the most critical for infections’ develop-
ment.33,34
The leaching curve show a little decrease around 24–
72 hours of release. This trend is probably due to the
precipitation of small amount of AgCl33,34 on samples’
surfaces soaked in SBF for less than 14 days, as
confirmed by SEM observation. The silver release is
performed in SBF, a solution rich in ions, in particular
phosphates, being able to complex silver ions and
increase the AgCl solubility. However, phosphates are
attracted by calcium ions, also present in great amount
in SBF; they precipitate as calcium phosphate and
crystallise as HAp on glass–ceramic surface during the
bioactivity process. Then, the solution is depleted in
phosphates and silver can precipitate as AgCl on
samples’ surfaces; for this reason, the amount of silver
in the solution decreases slowly during the leaching test.
Wettability test
Wettability measurements gave a mean static contact
angle of 65u for Fa-GC and of 72u for Ag-Fa-GC.
According to these values, ion exchanged samples are a
little more hydrophilic than simple glass–ceramic
(p,0?05). This can be explained by observation that
before ion exchange process, the glass–ceramic surface is
first characterised by O–Na bonds, while after the
treatment, O–Ag bonds are introduced. O–Na bond is
more polar than O–Ag bond, so water molecules present
a stronger attraction for an O–Na rich surface, which
makes them a little more hydrophilic.
Since many bacteria adhere preferably to hydrophilic
surfaces,39,40 the realisation of a more hydrophilic
surface can be an added power to the antibacterial
behaviour of silver to reduce the bacterial adhesion on
glass–ceramic.
Biocompatibility tests
Figure 12 reports some optical micrographs of osteo-
blasts after 4 day culture and shows a comparison
11 Silver release amount and rate
12 Optical observation after 4 day culture
13 Osteoblast’s viable count on control, Fa-GC and Ag-
GC
14 Inhibition zone evaluation: top of plate: Fa-GC sample;
below: three Ag-GC samples
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among a control, Fa-GC and Ag-GC. All images are
similar in cell morphology. The presence of a substantial
number of cells, which create a carpet on the culture
surface even for Fa-GC and Ag-GC, is an index of
material’s biocompatibility in both treated and
untreated forms. Viable count shows similar values for
control, Fa-GC and Ag-Fa-GC cultures after 2 days
(Fig. 13). The number of osteoblast in the samples after
8 days is lower in comparison with that of control, and it
is also slightly lower in comparison with the value after
4 days. The last observation is due probably to the
beginning of bioactivity process and the subsequently
ions release by glass–ceramic in culture medium. So the
viable count tests in both samples confirm that the
amount of introduced and as a consequence, released
silver does not influence significantly osteoblast’s adhe-
sion and proliferation.
pH value is 8?37 for basal medium. Table 2 shows pH
mean values for control, Fa-GC and Ag-GC; an
acidification after cell culture indicates active cellular
metabolism. There are not substantial differences among
control, treated and untreated samples.
The production of LDH in culture medium
increases with culture time for both samples, in
particular for Ag-GC samples after 8 days. The increase
in LDH in both samples in comparison with the
control can be due to ions (Naz) coming from the
glass during bioactivity process and ions and Agz
released respectively in untreated and treated
samples. The ions and Agz are accumulated in medium
and interfere with cell vitality, since culture medium
was not substituted during the 8 days of culture. On
the contrary, in the human body, a process of
clearance occurs: body fluids remove and clear the
products released from implant devices, inhibiting their
accumulation.
Antibacterial tests
The inhibition zone evaluation tests demonstrate the
effective antibacterial properties of silver ions: Ag-GC
samples are able to produce a significant and reprodu-
cible inhibition zone of growing bacteria, while the
bacteria colonies grown all around the Fa-GC untreated
specimens, tested as control (Fig. 14).
Quantitative information about antibacterial beha-
viour of silver doped samples is given by broth dilution
tests. The first information is given by McFarland index,
which is a measurement of broth turbidity: an increase
in turbidity is due to bacterial proliferation. Figure 15
shows that silver containing samples present a signifi-
cantly lower McFarland index (and a more limpid
solution) than GC ones.
Solution analysis describes bacterial proliferation in
the whole medium where both bacteria and samples
have been incubated. Washing solution quantifies
bacterial proliferation in the liquid film just around the
sample, while vortexing solution determines the amount
of bacteria adhered on samples’ surfaces and detached
by vortex treatment.
Broth and washing solutions present a reduction of
almost three orders of magnitude for silver containing
samples. The box in Fig. 16 underlines the amount of initial
bacterial inoculum (Figs. 16 and 17). In the vortexing
solution, a reduction of two orders of magnitude for treated
samples is shown (Fig. 18). A reduction of CFU adhered
on surfaces of samples is particularly significant since
adhered bacteria cause the effective infection and often lead
to a biofilm formation, i.e. a slime bacteria containing
surface hardly penetrated by common antibiotics which is
usually adopted to treat infections.
Table 2 pH and LDH values
pH LDH
2 days 4 days 8 days 2 days 4 days 8 days
Control 8.12 7.98 8.23 48.76 42.35 67
Fa-GC 7.97 7.88 7.77 34.4 2.64 295.5
Ag-GC 8.00 7.87 7.71 0 0 546
15 McFarland index
16 CFU count for broth
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Conclusions
The ion exchange technique, already experimented on
glass substrates, permits the introduction of low and
controlled amount of silver without modifying bulk
characteristics of bioactive glass–ceramic. The released
amount of silver detected by GF-AAS is lower than
those reported in literature for cytotoxic effect.
The material biocompatibility was confirmed also by
biological tests: osteoblast like cells adhere and prolif-
erate on both untreated and ion exchanged samples;
therefore, the introduced and released silver does not
cause cytotoxic effect, but confers only antimicrobial
activity toward S. Aureus, the most common bacterial
species that occurs in post-chirurgical infections.
This work confirmed that ion exchange method can be
applied to different and complex glass and glass–ceramic
compositions. It is extremely important to modify process
parameters, to introduce and release controlled silver
amounts (below clinical tolerance levels), and to verify
cytotoxic effect before antibacterial activity is attested.
Coming efforts will be focused on the translation of
this technique to glass–ceramic coated metallic devices,
such as external fixation implants, or bone substitutes.
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